|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.8 AUD | +0.24% |
|
+1.62% | +7.40% |
| Apr. 22 | Cochlear Limited Announces Company Secretary Changes | CI |
| Apr. 19 | Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old | CI |
Cochlear Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 1,098.5 million compared to AUD 885.2 million a year ago. Net income was AUD 191.4 million compared to AUD 141.6 million a year ago.
Basic earnings per share from continuing operations was AUD 2.919 compared to AUD 2.153 a year ago. Diluted earnings per share from continuing operations was AUD 2.913 compared to AUD 2.153 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.40% | 13.7B | |
| +1.84% | 24.07B | |
| +10.34% | 10.18B | |
| -17.75% | 2.06B | |
| +6.38% | 1.79B | |
| +41.47% | 1.73B | |
| +13.26% | 589M | |
| 0.00% | 400M | |
| +27.40% | 135M | |
| +21.80% | 93.49M |
COCHLEAR LIMITED 
